Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings.
STUDY BACKGROUND:Vitamin D has wide-ranging effects on the immune system, and studies suggest that low serum vitamin D levels are associated with worse clinical outcomes in HIV. Recent studies have identified an interaction between antiretrovirals used to treat HIV and reduced serum vitamin D levels...
Main Authors: | Fiona P Havers, Barbara Detrick, Sandra W Cardoso, Sima Berendes, Javier R Lama, Patcharaphan Sugandhavesa, Noluthando H Mwelase, Thomas B Campbell, Amita Gupta, ACTG A5175 PEARLS and NWCS319 Study Teams |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3994063?pdf=render |
Similar Items
-
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
by: Mark W Tenforde, et al.
Published: (2015-01-01) -
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study
by: Rupak Shivakoti, et al.
Published: (2018-09-01) -
Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma.
by: Ashwin Balagopal, et al.
Published: (2012-01-01) -
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.
by: Steven A Safren, et al.
Published: (2014-01-01) -
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
by: Thomas B Campbell, et al.
Published: (2012-01-01)